Vifor Pharma: Manufacturer offers NHS 23m in response to investigation into misleading claims about rival treatment

Drugs manufacturer Vifor Pharma has offered to pay £23m to the NHS in response to an investigation by the Competition and Markets Authority (CMA) into whether the company had broken competition law by spreading misinformation about a rival product. The CMA opened an investigation in January 2024 into whether Vifor Pharma, which manufactures the IV [...]The post Manufacturer offers NHS £23m in response to investigation into misleading claims about rival treatment appeared first on The Pharmaceutical Journal.